GlassScriptPhysician profile
Leslie A Oldham
NPI 1164880506
$1,278.43
in general payments reported to CMS, 2019-2025
19 companies · $671 in 2025
The $671 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $291 · 2023: $15.44 · 2024: $134 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $243.16 | 2025 | Zurzuvae |
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.84 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $125.13 | 2021-2024 | Breztri, Airsupra, Farxiga |
| Mayne Pharma Commercial LLC | $105.92 | 2025 | |
| Novo Nordisk INC | $94.35 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $84.94 | 2025 | Myfembree |
| Janssen Pharmaceuticals, INC | $69.74 | 2022 | |
| Millicent US INC | $49.66 | 2025 | Femlyv |
| Exeltis, USA INC. | $47.84 | 2025 | Slynd |
| Astellas Pharma US INC | $26.50 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $25.62 | 2025 | Aptima, Thinprep 2000 Processor |
| Supernus Pharmaceuticals, INC. | $23.92 | 2025 | Qelbree |
| Abbvie INC. | $23.81 | 2022 | |
| Coopersurgical, INC. | $22.19 | 2025 | Paragard T 380a |
| Exact Sciences Corporation | $22.15 | 2025 | The Cologuard Plus Collection Kit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $21.94 | 2021 | |
| Ferring Pharmaceuticals INC. | $21.52 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.76 | 2025 | |
| Pfizer INC. | $15.44 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Oldham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.